- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-MyoAAV 4A Rep-Cap plasmid (serotype MyoAAV 4A - specific AAV RC-MyoAAV 4A plasmids) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi's MyoAAV 4A Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the MyoAAV 4A capsid protein.
You can produce MyoAAV 4A particle in 293T cell line in high titer using GeneMedi's MyoAAV 4A Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
This variant, leveraging the unique properties of AAV4, could be engineered for selective targeting of muscle cells, potentially including smooth muscle tissues not efficiently targeted by other AAV serotypes. Modifications could include capsid changes for enhanced muscle cell entry or the use of regulatory elements that drive gene expression specifically in muscle tissues.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids.
Go to AAV
vector system
>>
Map Download
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-RC33 | AAV-MyoAAV 4A Rep-Cap Plasmid (Amp resistance) Size：5ug | Academic | 2062 | ||
| P-RC33 | AAV-MyoAAV 4A Rep-Cap Plasmid (Amp resistance) Size：5ug | Biotech & Pharma & Medical Device & Diagnostics | |||
| P-RC33 | AAV-MyoAAV 4A Rep-Cap Plasmid (Amp resistance) Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC33 | AAV-MyoAAV 4A Rep-Cap Plasmid (Amp resistance) Size：≥10mg |
All | |||
| P-RC33-Kan | AAV-MyoAAV 4A Rep-Cap Plasmid (Kan resistance) Size：≥10mg |
All | |||
| P-PK33 | AAV-MyoAAV 4A Vector
System (Amp resistance)
1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug |
Academic | 3379 | ||
| P-PK33 | AAV-MyoAAV 4A Vector
System (Amp resistance)
1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Biotech & Pharma & Medical Device & Diagnostics | |||
| P-PK33 | AAV-MyoAAV 4A Vector
System (Amp resistance)
1. MyoAAV 4A Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK33 | AAV-MyoAAV 4A Vector
System (Amp resistance)
1. MyoAAV 4A Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK33-Kan | AAV-MyoAAV 4A Vector
System(Kan resistance)
1. MyoAAV 4A Rep-Cap Plasmid(Kan resistance), ≥10mg 2. AAV Helper Plasmid(Kan resistance), ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Rep-Cap Plasmid. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Rep-Cap Plasmid currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARa and Inhibition of p53-Mediated Senescence | Cancer Cell | 2017/5/8 |
| Laterodorsal tegmentum interneuron subtypes oppositely regulate olfactory cue-induced innate fear | NATURE NEUROSCIENCE | 2016/6/26 |
| HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells | Signal Transduction and Targeted Therapy | 2021/11/24 |
| Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive‐Like Disorders by Promoting ATP Production | Advanced Science | 2022/11/22 |
| Skin chronological aging drives age-related bone loss via secretion of cystatin-A | Nature Aging | 2022/10/6 |
| Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis | Science Advances | 2023/2/8 |
| Capturing dynamic biological signals via bio-mimicking hydrogel for precise remodeling of soft tissue | Bioactive Materials | 2021/5/11 |
| A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury | Molecular Psychiatry | 2022/8/2 |
| Extracellular vesicle-derived CircWhsc1 Promotes Cardiomyocyte Proliferation and Heart Repair by activating TRIM59/STAT3/Cyclin B2 pathway | Journal of Advanced Research | 2022/12/29 |
| Circular RNA CREBBP modulates cartilage degradation by activating the Smad1/5 pathway through the TGFβ2/ALK1 axis | Experimental & Molecular Medicine | 2022/10/12 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
